Revapharma Private Limited

Pharmaceutical company producing tablets, capsules, liquids, injectables, creams, veterinary, cosmetic, herbal, and surgical items.

2019 | East Delhi, Delhi (India) | Converted to LLP
Last Updated:

Revapharma Profile

Key Indicators

  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 6 Year, 1 Month
  • Last Filing with ROC 31 Mar 2019

About Revapharma

Revapharma Private Limited (RPL) is Converted To Llp company established on 26 Mar 2019 with its office registered at East Delhi, Delhi, India and has been running since 6 Year, 1 Month with a paid up capital of 0.10 M. According to MCA records, 0 Directors are linked to this company as of 22 Apr 2024.

Company Details

  • Location

    East Delhi, Delhi, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24299DL2019PTC347678

  • Company No.

    347678

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    26 Mar 2019

  • Date of AGM

    31 Oct 2019

  • Date of Balance Sheet

    31 Mar 2019

  • Listing Status

    Unlisted

  • ROC Code

    Roc-Delhi

Industry

Pharma
Company report

Revapharma Private Limited

Explore comprehensive data for Revapharma Private Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Revapharma?

Board Members

People

No Directors or KMP associated with company. Upon reviewing the records, we can confirm that there are no Directors or Key Management Personnel (KMP) associated with this company at present.

Financial Performance of Revapharma.

Revapharma Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Revapharma revenue growth over time
Revapharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

What is the Ownership and Shareholding Structure of Revapharma?

In 2019, Revapharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Revapharma?

Unlock and access historical data on people associated with Revapharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Revapharma Private Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Revapharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Revapharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Revapharma

Recent activity within the organization

  • Annual General Meeting

    Revapharma Private Limited last Annual general meeting of members was held on 31 Oct 2019 as per latest MCA records.

  • Balance Sheet

    Revapharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with RoC-Delhi.

  • Company Incorporation

    Revapharma Private Limited was registered on 26 Mar 2019 with RoC-Delhi & aged 6 years 1 month as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Revapharma Private Limited?

    Revapharma Private Limited was incorporated on 26 Mar 2019.

  • What is authorized share capital and paid-up capital of Revapharma Private Limited?

    The authorized share capital of Revapharma Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • What is the registered address of Revapharma Private Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Revapharma Private Limited is Shop No. 304 2Nd Floor Plot No. 3 L.S.C., Blk-G Kondli Gharoli Mayur Vihar Phase-Iii, Delhi, India, 110096.

  • What is the corporate identification number (CIN) and company number of Revapharma Private Limited?

    The corporate identification number (CIN) of Revapharma Private Limited is U24299DL2019PTC347678 and the company number is 347678 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Revapharma Private Limited?

    The Official website of Revapharma Private Limited is https://www.revapharma.in

  • When was the last Balance Sheet of Revapharma Private Limited filed with the ROC?

    The most recent Balance Sheet for Revapharma Private Limited was filed with the ROC on 31 Mar 2019.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development